Accumulating evidence suggests that high levels of Fusobacterium nucleatum in colorectal
tumor tissues can be associated with poor prognosis in patients with colorectal cancer …

Colorectal cancer (CRC) is one of the most common malignant tumors and is associated
with Fusobacterium nucleatum (F. nucleatum, Fn) infection. In this study, we explored the …

Background Fusobacterium nucleatum has been recognized as an important key bacterium
in the cause and spread of colorectal carcinogenesis. Nevertheless, the clinical relevance of …

Abstract Purpose of Review To summarize the relationship between colorectal cancer
(CRC), immunity, and the gut microbiome, focusing on the population of Fusobacterium …

Background/Aims Growing evidence supports the direct link of Fusobacterium nucleatum
with colorectal cancer (CRC). However, to date, the underlying mechanism of action remains …

Colorectal cancer (CRC) is the third most frequent malignant tumor. The gut microbiome acts
as a vital component of CRC etiology. Fusobacterium nucleatum (Fn) is a key member of …

Fusobacterium (F.) nucleatum is a carcinogenesis microbiota in colorectal cancer (CRC).
Growing evidence shows that F. nucleatum contributes to chemoresistance. Ferroptosis is …

Colorectal cancer (CRC) is a common malignant tumor that affects people worldwide.
Metagenomic analyses have shown an enrichment of Fusobacterium nucleatum (F …

AIM To examine the effect of Fusobacterium nucleatum (F. nucleatum) on the
microenvironment of colonic neoplasms and the expression of inflammatory mediators and …

Colorectal cancer (CRC) is a common digestive malignancy and emerging studies have
closely linked its initiation and development with gut microbiota changes. Fusobacterium …